4 completed, 2 terminated, 1 unknown, 1 withdrawn. 8 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 4, Terminated 2, Unknown 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Dexetimide: new trials by email Literature Review of Dexetimide trials Research Report on Dexetimide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Canadian Biomarker Integration Network for Depression (CAN-BIND) - Validation Study Escitalopram, Brexpiprazole - Major Depressive Disorder | Phase 3 | Completed | University Health Network, Toronto | 1 | 2019-12-23 | 2023-03-02 |
| The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients Escitalopram, placebo - GBM, Depression | Phase 2 / Phase 3 | Unknown | Tel-Aviv Sourasky Medical Center | 100 | 2015-12-01 | 2015-12-07 |
| Canadian Biomarker Integration Network for Depression Study escitalopram, aripiprazole - Major Depressive Disorder | Phase 3 | Completed | University Health Network, Toronto | 211 | 2012-04-23 | 2018-05-11 |
| Antidepressants and Bone Mineral Density sertraline, citalopram, venlafaxine - Bone Mineral Density Quantitative Trait Locus 7 | Phase 3 | Completed | Guiyang Medical University | 203 | 2012-03-01 | 2014-07-01 |
| Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder. Escitalopram, Bupropion XL - Bipolar I Disorder | Phase 3 | Terminated | University of British Columbia | 237 | 2010-11-01 | 2025-05-15 |
| EScitalopram PIndolol ONset of Action escitalopram, pindolol, escitalopram - Unipolar Depression | Phase 2 / Phase 3 | Terminated | Markus KOSEL | 18 | 2010-10-01 | 2015-05-27 |
| Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression S-citalopram, Cognitive behavioral therapy (CBT), TRODAT-1 single photon emission computed tomographic (SPECT) imaging - Depression | Phase 2 / Phase 3 | Completed | University of Pennsylvania | 66 | 2005-10-01 | 2020-04-16 |
| Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) Exacerbations escitalopram - Anxiety, COPD | Phase 3 | Withdrawn | Hull University Teaching Hospitals NHS Trust | 2017-03-29 |
Depression (3) · Depressive Disorder, Major (2) · Anxiety Disorders (1) · Depressive Disorder (1) · Pulmonary Disease, Chronic Obstructive (1)
University Health Network, Toronto (2) · Guiyang Medical University (1) · Hull University Teaching Hospitals NHS Trust (1) · Markus KOSEL (1) · Tel-Aviv Sourasky Medical Center (1) · University of British Columbia (1) · University of Pennsylvania (1)
Canada (3) · Israel (1) · Switzerland (1) · United Kingdom (1) · United States (1)
A. Daigneault, Dr. (1) · A. Ravindran, Dr. (1) · A. Schaffer, Dr. (1) · A.V. Mysore, Dr. (1) · Alyn H Morice, Professor (1) · B. Frey, Dr. (1) · J. Y. Reddy, Dr. (1) · Jay D. Amsterdam, MD (1) · Lakshmi Yatham, Dr. (1) · M.S. Reddy, Dr. (1) · Markus Kosel, MD-PhD (1) · P. Cervantes, Dr. (1) · P.S. Sharma, Dr. (1) · R. Milev, Dr. (1) · Rachel Grossman, MD (1)
PMID 30840787, PMID 31471185, PMID 32349119, PMID 32558407, PMID 33296696, PMID 33520402, PMID 33683582, PMID 33860922, PMID 34008342, PMID 34229186, PMID 34416758, PMID 35023065, PMID 35546043, PMID 37530824, PMID 37796764, PMID 37967350, PMID 38128154
R34MH070753 (1)